Author details

Full Name

Patrick B Ryan

Affiliation

Columbia University Irving Medical Center

ORCID

Career Start Year

2010

Papers

189

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38010062	Bayesian safety surveillance with adaptive bias correction.	Stat Med	2024
38010062	Bayesian safety surveillance with adaptive bias correction.	Stat Med	2024
36826399	Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.	J Am Med Inform Assoc	2023
37598737	PadÃ© approximant meets federated learning: A nearly lossless, one-shot algorithm for evidence synthesis in distributed research networks with rare outcomes.	J Biomed Inform	2023
37034358	Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.	EClinicalMedicine	2023
36826399	Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.	J Am Med Inform Assoc	2023
37328600	Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.	Drug Saf	2023
37128407	Phenotyping in distributed data networks: selecting the right codes for the right patients.	AMIA Annu Symp Proc	2023
36991144	A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases.	NPJ Digit Med	2023
37598737	PadÃ© approximant meets federated learning: A nearly lossless, one-shot algorithm for evidence synthesis in distributed research networks with rare outcomes.	J Biomed Inform	2023
36991144	A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases.	NPJ Digit Med	2023
37034358	Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.	EClinicalMedicine	2023
37328600	Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.	Drug Saf	2023
37128407	Phenotyping in distributed data networks: selecting the right codes for the right patients.	AMIA Annu Symp Proc	2023
34870731	90-Day all-cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model.	Knee Surg Sports Traumatol Arthrosc	2022
35392566	Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.	Front Pharmacol	2022
35653017	Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.	Drug Saf	2022
35579818	Using Iterative Pairwise External Validation to Contextualize Prediction Model Performance: A Use Case Predicting 1-Year Heart Failure Risk in Patients with Diabetes Across Five Data Sources.	Drug Saf	2022
35429722	Logistic regression models for patient-level prediction based on massive observational data: Do we need all data?	Int J Med Inform	2022
35873596	Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs.	Front Pharmacol	2022
35559254	Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases.	Front Pharmacol	2022
36207711	Adaptation and validation of a coding algorithm for the Charlson Comorbidity Index in administrative claims data using the SNOMED CT standardized vocabulary.	BMC Med Inform Decis Mak	2022
35680274	Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.	BMJ Open	2022
35995107	PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation.	J Biomed Inform	2022
35614485	Learning patient-level prediction models across multiple healthcare databases: evaluation of ensembles for increasing model transportability.	BMC Med Inform Decis Mak	2022
35482996	Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study.	JMIR Public Health Surveill	2022
35354802	DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models.	Nat Commun	2022
36188566	International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.	Front Pharmacol	2022
36506524	Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.	Front Pharmacol	2022
34870731	90-Day all-cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model.	Knee Surg Sports Traumatol Arthrosc	2022
35094685	Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.	BMC Med Res Methodol	2022
35345821	Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.	Clin Epidemiol	2022
35680274	Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.	BMJ Open	2022
35653017	Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.	Drug Saf	2022
35614485	Learning patient-level prediction models across multiple healthcare databases: evaluation of ensembles for increasing model transportability.	BMC Med Inform Decis Mak	2022
35579818	Using Iterative Pairwise External Validation to Contextualize Prediction Model Performance: A Use Case Predicting 1-Year Heart Failure Risk in Patients with Diabetes Across Five Data Sources.	Drug Saf	2022
35345821	Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS.	Clin Epidemiol	2022
35429722	Logistic regression models for patient-level prediction based on massive observational data: Do we need all data?	Int J Med Inform	2022
35392566	Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.	Front Pharmacol	2022
35559254	Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases.	Front Pharmacol	2022
35482996	Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study.	JMIR Public Health Surveill	2022
35354802	DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models.	Nat Commun	2022
36506524	Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.	Front Pharmacol	2022
35873596	Vaccine Safety Surveillance Using Routinely Collected Healthcare Data-An Empirical Evaluation of Epidemiological Designs.	Front Pharmacol	2022
36207711	Adaptation and validation of a coding algorithm for the Charlson Comorbidity Index in administrative claims data using the SNOMED CT standardized vocabulary.	BMC Med Inform Decis Mak	2022
35995107	PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation.	J Biomed Inform	2022
36188566	International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.	Front Pharmacol	2022
35094685	Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.	BMC Med Res Methodol	2022
33260201	Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.	J Am Med Inform Assoc	2021
35727911	Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.	BMJ	2021

1 - 50 of 378

Brett K Beaulieu-Jones

University of Chicago

Career Start Year 2016

Number of shared co-authors 6

Yong Chen

the Perelman School of Medicine, University of Pennsylvania

Career Start Year 2015

Number of shared co-authors 16

Yoonyoung Park

Moderna Inc.

Career Start Year 2015

Number of shared co-authors 2

Jing Huang

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia

Career Start Year 2014

Number of shared co-authors 5

Justin Bohn

Harvard Medical School and Harvard Pilgrim Health Care Institute

Career Start Year 2012

Number of shared co-authors 4

Hemalkumar B Mehta

Johns Hopkins Bloomberg School of Public Health

Career Start Year 2012

Number of shared co-authors 4

Yue Yu

Health Sciences Mayo Clinic

Career Start Year 2012

Number of shared co-authors 4

Rishi J Desai

Harvard Medical School

Career Start Year 2011

Number of shared co-authors 13

Gyorgy Simon

Institute for Health Informatics, University of Minnesota

Career Start Year 2011

Number of shared co-authors 2

Orestis A Panagiotou

Department of Health Services, Brown University School of Public Health

Career Start Year 2010

Number of shared co-authors 1

Victor M Castro

Center for Quantitative Health, Massachusetts General Hospital

Career Start Year 2010

Number of shared co-authors 4

Judith C Maro

Harvard Pilgrim Health Care Institute and Harvard Medical School

Career Start Year 2009

Number of shared co-authors 8

Shirley V Wang

Brigham and Women's Hospital, Harvard Medical School

Career Start Year 2009

Number of shared co-authors 14

Susan M Shortreed

Kaiser Permanente Washington Health Research Institute

Career Start Year 2008

Number of shared co-authors 1

Elisabetta Patorno

Harvard Medical School

Career Start Year 2006

Number of shared co-authors 8

Sherri Rose

Stanford University

Career Start Year 2006

Number of shared co-authors 1

Christine Y Lu

Harvard Medical School and the Harvard Pilgrim Health Care Institute

Career Start Year 2004

Number of shared co-authors 4

Terrence J Adam

University of Minnesota, Institute for Health Informatics.

Career Start Year 2002

Number of shared co-authors 1

Michele Jonsson Funk

University of North Carolina at Chapel Hill

Career Start Year 2002

Number of shared co-authors 7

Qingxia Chen

Vanderbilt University Medical Center

Career Start Year 2002

Number of shared co-authors 6

Josh F Peterson

Vanderbilt University Medical Center

Career Start Year 2001

Number of shared co-authors 12

Pedro J Caraballo

Mayo Clinic

Career Start Year 1999

Number of shared co-authors 6

Tina Hernandez-Boussard

Stanford University

Career Start Year 1998

Number of shared co-authors 5

Manisha Desai

Stanford University

Career Start Year 1997

Number of shared co-authors 4

Emily Beth Devine

University of Washington

Career Start Year 1997

Number of shared co-authors 4

Jonathan S Schildcrout

Vanderbilt University Medical Center.

Career Start Year 1997

Number of shared co-authors 5

Peggy L Peissig

Center for Precision Medicine Research, Marshfield Clinic Research Institute

Career Start Year 1996

Number of shared co-authors 7

William R Hogan

College of Medicine, University of Florida

Career Start Year 1990

Number of shared co-authors 10

Til St??rmer

University of North Carolina at Chapel Hill

Career Start Year 1988

Number of shared co-authors 14

Mark G Weiner

Weill Cornell Medical College

Career Start Year 1987

Number of shared co-authors 15

row(s) 1 - 30 of 30

Martijn J Schuemie

University of California los angeles

Co-authored papers 87

George Hripcsak

Columbia University

Co-authored papers 65

Marc A Suchard

University of California los angeles

Co-authored papers 63

Christian Reich

OHDSI Center at The Roux Institute, Northeastern University

Co-authored papers 42

David Madigan

Columbia University.

Co-authored papers 41

Peter R Rijnbeek

Erasmus University Medical Center

Co-authored papers 40

Daniel Prieto-Alhambra

University of Oxford

Co-authored papers 29

Seng Chan You

Yonsei University College of Medicine

Co-authored papers 29

Talita Duarte-Salles

Erasmus University Medical Center

Co-authored papers 27

Nigam H Shah

Stanford University

Co-authored papers 25

Jenna M Reps

Erasmus University Medical Center

Co-authored papers 25

Fred Nyberg

University of Gothenburg

Co-authored papers 22

Thamir M Alshammari

Riyadh Elm University

Co-authored papers 22

Rae Woong Park

Ajou University Graduate School of Medicine

Co-authored papers 22

Nicole L Pratt

Quality Use of Medicines and Pharmacy Research Centre, University of South Australia

Co-authored papers 20

Daniel R Morales

University of Dundee

Co-authored papers 20

Kristine E Lynch

University of Utah Health

Co-authored papers 20

Michael Matheny

American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School

Co-authored papers 19

Scott L DuVall

University of Utah

Co-authored papers 19

Frank DeFalco

Janssen Pharmaceutical Research & Development

Co-authored papers 18

Clair Blacketer

Erasmus University Medical Center

Co-authored papers 17

Michael E Matheny

Co-authored papers 17